Vicki Waetzig

2.5k total citations
38 papers, 2.1k citations indexed

About

Vicki Waetzig is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Vicki Waetzig has authored 38 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 4 papers in Neurology. Recurrent topics in Vicki Waetzig's work include Melanoma and MAPK Pathways (21 papers), Protein Kinase Regulation and GTPase Signaling (12 papers) and Cell death mechanisms and regulation (10 papers). Vicki Waetzig is often cited by papers focused on Melanoma and MAPK Pathways (21 papers), Protein Kinase Regulation and GTPase Signaling (12 papers) and Cell death mechanisms and regulation (10 papers). Vicki Waetzig collaborates with scholars based in Germany, Austria and Denmark. Vicki Waetzig's co-authors include Thomas Herdegen, Wiebke Haeusgen, Yi Zhao, Stephan Brecht, Mario E. Goetz, Kirsten Mielke, Uwe‐Karsten Hanisch, Malte Christian Claussen, Alexa Klettner and K. Czeloth and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.

In The Last Decade

Vicki Waetzig

37 papers receiving 2.1k citations

Peers

Vicki Waetzig
Larry A. Wheeler United States
Byron D. Ford United States
Young Soo Ahn South Korea
Alexander G. Yakovlev United States
Larry Denner United States
Sung‐Jen Wei United States
Ron J. Bouchard United States
Daniele Bano Germany
Arundhati Jana United States
Larry A. Wheeler United States
Vicki Waetzig
Citations per year, relative to Vicki Waetzig Vicki Waetzig (= 1×) peers Larry A. Wheeler

Countries citing papers authored by Vicki Waetzig

Since Specialization
Citations

This map shows the geographic impact of Vicki Waetzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicki Waetzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicki Waetzig more than expected).

Fields of papers citing papers by Vicki Waetzig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicki Waetzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicki Waetzig. The network helps show where Vicki Waetzig may publish in the future.

Co-authorship network of co-authors of Vicki Waetzig

This figure shows the co-authorship network connecting the top 25 collaborators of Vicki Waetzig. A scholar is included among the top collaborators of Vicki Waetzig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicki Waetzig. Vicki Waetzig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bruckmueller, Henrike, et al.. (2024). Regulation and Function of CCL2 and N-Myc in Retinoic Acid-treated Neuroblastoma Cells. Cancer Genomics & Proteomics. 22(1). 90–102.
2.
Cascorbi, Ingolf, et al.. (2024). Enhancing Retinoic Acid-mediated Effects Through Inhibition of CYP26A1, CYP26B1 and HGF Signaling in Neuroblastoma Cells. Anticancer Research. 44(10). 4189–4202. 1 indexed citations
3.
Waetzig, Vicki, et al.. (2017). Crosstalk control and limits of physiological c-Jun N-terminal kinase activity for cell viability and neurite stability in differentiated PC12 cells. Molecular and Cellular Neuroscience. 82. 12–22. 3 indexed citations
4.
Waetzig, Vicki, et al.. (2017). Neurodegenerative effects of azithromycin in differentiated PC12 cells. European Journal of Pharmacology. 809. 1–12. 13 indexed citations
5.
Haeusgen, Wiebke, et al.. (2014). Map2k4δ — Identification and functional characterization of a novel Map2k4 splice variant. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(5). 875–884. 8 indexed citations
6.
Jung, Sascha, Frank D. Sönnichsen, Chien‐Wen Hung, et al.. (2012). Macin Family of Antimicrobial Proteins Combines Antimicrobial and Nerve Repair Activities. Journal of Biological Chemistry. 287(17). 14246–14258. 44 indexed citations
7.
Haeusgen, Wiebke, Thomas Herdegen, & Vicki Waetzig. (2011). MKK7γ1 reverses nerve growth factor signals: Proliferation and cell death instead of neuritogenesis and protection. Cellular Signalling. 23(8). 1281–1290. 8 indexed citations
8.
Klettner, Alexa, Stefan Koinzer, Vicki Waetzig, Thomas Herdegen, & Johann Roider. (2010). Deferoxamine mesylate is toxic for retinal pigment epithelium cellsin vitro, and its toxicity is mediated by p38. Cutaneous and Ocular Toxicology. 29(2). 122–129. 31 indexed citations
9.
Haeusgen, Wiebke, et al.. (2009). Specific activities of individual c-Jun N-terminal kinases in the brain. Neuroscience. 161(4). 951–959. 77 indexed citations
10.
Brecht, Stephan, Vicki Waetzig, Uwe‐Karsten Hanisch, et al.. (2009). FK506 Protects Against Various Immune Responses and Secondary Degeneration Following Cerebral Ischemia. The Anatomical Record. 292(12). 1993–2001. 19 indexed citations
11.
Waetzig, Vicki, Wiebke Haeusgen, Benny Björkblom, et al.. (2009). Concurrent protective and destructive signaling of JNK2 in neuroblastoma cells. Cellular Signalling. 21(6). 873–880. 12 indexed citations
12.
Waetzig, Vicki, et al.. (2008). c‐Jun N‐terminal kinases trigger both degeneration and neurite outgrowth in primary hippocampal and cortical neurons. Journal of Neurochemistry. 104(4). 957–969. 45 indexed citations
13.
Claussen, Malte Christian, Gregor Fuhrmann, Lewis H. Romer, et al.. (2007). Luteolin protects rat PC 12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keapl-Nrf2-ARE pathway. PubMed. 57–67. 160 indexed citations
14.
Waetzig, Vicki, Yi Zhao, & Thomas Herdegen. (2006). The bright side of JNKs—Multitalented mediators in neuronal sprouting, brain development and nerve fiber regeneration. Progress in Neurobiology. 80(2). 84–97. 114 indexed citations
15.
Waetzig, Vicki & Thomas Herdegen. (2005). Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage. Trends in Pharmacological Sciences. 26(9). 455–61. 135 indexed citations
16.
Waetzig, Vicki, K. Czeloth, Kirsten Mielke, et al.. (2005). c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia. 50(3). 235–246. 262 indexed citations
17.
Klettner, Alexa, et al.. (2004). JNK2 Translocates to the Mitochondria and Mediates Cytochrome c Release in PC12 Cells in Response to 6-Hydroxydopamine. Journal of Biological Chemistry. 279(53). 55385–55392. 92 indexed citations
18.
Brecht, Stephan, Katrin Schwarze, Vicki Waetzig, et al.. (2003). Changes in peptidyl-prolyl cis/trans isomerase activity and fk506 binding protein expression following neuroprotection by fk506 in the ischemic rat brain. Neuroscience. 120(4). 1037–1048. 35 indexed citations
19.
Waetzig, Vicki & Thomas Herdegen. (2003). The concerted signaling of ERK1/2 and JNKs is essential for PC12 cell neuritogenesis and converges at the level of target proteins. Molecular and Cellular Neuroscience. 24(1). 238–249. 70 indexed citations
20.
Herdegen, Thomas & Vicki Waetzig. (2001). AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene. 20(19). 2424–2437. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026